Results from a randomized controlled trial of zonisamide in the treatment of alcohol use disorder

This publication has 39 references indexed in Scilit:

• Efficacy of Gabapentin for the Treatment of Alcohol Use Disorder in Patients With Alcohol Withdrawal Symptoms
  JAMA Internal Medicine, 2020
• An exploratory evaluation of Take Control : A novel computer-delivered behavioral platform for placebo-controlled pharmacotherapy trials for alcohol use disorder
  Contemporary Clinical Trials, 2016
• Pharmacotherapy for Adults With Alcohol Use Disorders in Outpatient Settings
  JAMA, 2014
• Zonisamide up-regulated the mRNAs encoding astrocytic anti-oxidative and neurotrophic factors
  European Journal of Pharmacology, 2012
• HRD1 Levels Increased by Zonisamide Prevented Cell Death and Caspase-3 Activation Caused by Endoplasmic Reticulum Stress in SH-SY5Y Cells
  Journal of Molecular Neuroscience, 2011
• Improvement of Physical Health and Quality of Life of Alcohol-Dependent Individuals With Topiramate TreatmentUS Multisite Randomized Controlled Trial
  Archives of internal medicine (1960), 2008
• Zonisamide at clinically relevant concentrations inhibits field EPSP but not presynaptic fiber volley in rat frontal cortex
  Epilepsy Research, 2005
• Lithium differs from anticonvulsant mood stabilizers in prefrontal cortical and accumbal dopamine release: Role of 5-HT1A receptor agonism
  Brain Research, 2005
• Effects of zonisamide on dopaminergic system
  Epilepsy Research, 1995
• Timeline Follow-Back
  1992